Madison, United States
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U. S. Multi-Society Task Force on Colorectal Cancer. For more information on Exact Sciences' noninvasive colon cancer screening test, visit CologuardTest.com
14
Total Investments
13
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Life Sciences
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Exact Sciences
Recent Investments (14)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Grant | •••••• | Jul 2024 | |
| Grant | •••••• | Dec 2023 | |
| Grant | •••••• | Dec 2023 | |
| Grant | •••••• | Dec 2023 | |
| Grant | •••••• | Dec 2023 | |
•••• ••••
|
Grant | •••••• | May 2023 |
|
•••• ••••
|
Grant | •••••• | May 2023 |
|
•••• ••••
|
Grant | •••••• | May 2023 |
|
•••• ••••
|
Grant | •••••• | May 2023 |
|
•••• ••••
|
Grant | •••••• | May 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
